Testing effectiveness (Phase 2)Ended earlyNCT01129024
What this trial is testing
An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP)
Who this might be right for
Immune Thrombocytopenia
Shionogi 19